Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

Go back to Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
(NASDAQ: NTLA) Delayed: 12.74 --0 (-0%)
Previous Close $12.74    52 Week High $30.40 
Open $12.74    52 Week Low $11.86 
Day High $12.74    P/E N/A 
Day Low $12.74    EPS $0.00 
Volume 49,607